Workflow
QFII持股
icon
Search documents
天地数码跌2.05%,成交额4743.80万元,主力资金净流出75.54万元
Xin Lang Cai Jing· 2025-09-19 06:07
Core Viewpoint - TianDi Digital's stock price has experienced fluctuations, with a year-to-date increase of 23.37% but a recent decline over various trading periods, indicating potential volatility in investor sentiment [2]. Company Overview - TianDi Digital, established on April 27, 2002, and listed on April 27, 2018, is located in Hangzhou, Zhejiang Province. The company specializes in the research, production, and sales of thermal transfer ribbon products [2]. - The main revenue composition includes barcode ribbons (88.67%), other products (9.78%), water transfer ribbons (0.66%), coding ribbons (0.55%), and fax ribbons (0.33%) [2]. - The company is categorized under the Shenwan industry classification of Computer - Computer Equipment - Other Computer Equipment, and is associated with concepts such as micro-cap stocks, small-cap stocks, specialized and innovative enterprises, QFII holdings, and the Internet of Things [2]. Financial Performance - For the first half of 2025, TianDi Digital achieved operating revenue of 431 million yuan, representing a year-on-year growth of 19.58%. The net profit attributable to shareholders was 62.61 million yuan, reflecting a year-on-year increase of 32.37% [2]. - Since its A-share listing, the company has distributed a total of 265 million yuan in dividends, with 162 million yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders for TianDi Digital was 13,200, a decrease of 0.31% from the previous period. The average number of circulating shares per shareholder was 9,614, down by 1.41% [2]. - Notable institutional holdings include Noan Pioneer Mixed A (320003) as the fifth-largest shareholder with 3.68 million shares, an increase of 1.86 million shares from the previous period, and交银启诚混合A (014038) as the eighth-largest shareholder with 2.39 million shares, marking a new entry [3].
西藏药业跌2.00%,成交额2.72亿元,主力资金净流出1477.81万元
Xin Lang Zheng Quan· 2025-09-19 06:02
Company Overview - Tibet Pharmaceutical Co., Ltd. is located in Lhasa Economic and Technological Development Zone, Tibet, and was established on July 14, 1999, with its listing date on July 21, 1999. The company primarily engages in pharmaceutical manufacturing, with 99.80% of its revenue coming from drug sales and 0.20% from other sources [1]. Stock Performance - As of September 19, the stock price of Tibet Pharmaceutical fell by 2.00% to 51.34 CNY per share, with a trading volume of 272 million CNY and a turnover rate of 1.62%. The total market capitalization is 16.548 billion CNY [1]. - Year-to-date, the stock has increased by 46.40%, but it has decreased by 9.02% over the last five trading days. In the last 20 days, the stock rose by 13.69%, and over the past 60 days, it increased by 43.49% [1]. Financial Performance - For the first half of 2025, Tibet Pharmaceutical reported a revenue of 1.651 billion CNY, representing a year-on-year growth of 2.23%. However, the net profit attributable to shareholders decreased by 8.96% to 567 million CNY [2]. Shareholder Information - As of June 30, 2025, the number of shareholders for Tibet Pharmaceutical was 45,200, a decrease of 8.08% from the previous period. The average number of circulating shares per person increased by 8.79% to 7,132 shares [2]. - The company has distributed a total of 2.258 billion CNY in dividends since its A-share listing, with 1.580 billion CNY distributed over the last three years [3]. Institutional Holdings - As of June 30, 2025, Hong Kong Central Clearing Limited was the seventh-largest circulating shareholder, holding 2.5902 million shares, a decrease of 1.6084 million shares from the previous period. Huaxia Industry Prosperity Mixed Fund (003567) was the tenth-largest circulating shareholder, maintaining its holding of 1.9036 million shares [3].
王子新材跌2.03%,成交额2.83亿元,主力资金净流出4187.93万元
Xin Lang Cai Jing· 2025-09-19 05:44
Company Overview - Wangzi New Materials Co., Ltd. is located in Longhua District, Shenzhen, Guangdong Province, established on May 28, 1997, and listed on December 3, 2014 [1] - The company's main business involves the research, design, production, and sales of plastic packaging materials and products [1] - Revenue composition includes: plastic packaging products 63.77%, electronic components 25.19%, others 6.58%, and military electronic products 4.46% [1] Stock Performance - As of September 19, Wangzi New Materials' stock price decreased by 2.03%, trading at 15.41 CNY per share, with a total market capitalization of 5.887 billion CNY [1] - Year-to-date, the stock price has increased by 66.65%, but it has seen a decline of 7.00% over the last five trading days and a slight decrease of 1.85% over the last 20 days [1] - The company has appeared on the trading leaderboard 17 times this year, with the most recent appearance on September 1, where it recorded a net buy of -94.20 million CNY [1] Financial Performance - For the first half of 2025, Wangzi New Materials achieved a revenue of 999 million CNY, representing a year-on-year growth of 18.45% [2] - The net profit attributable to the parent company was 15.70 million CNY, reflecting a year-on-year increase of 33.59% [2] - Cumulative cash dividends since the A-share listing amount to 109 million CNY, with 39.10 million CNY distributed over the last three years [3] Shareholder Information - As of June 30, 2025, the number of shareholders increased by 68.57% to 68,100, while the average circulating shares per person decreased by 40.70% to 4,118 shares [2] - Among the top ten circulating shareholders, Huaxia High-end Manufacturing Mixed A (002345) is the newest shareholder, holding 1.6197 million shares [3]
金安国纪跌2.02%,成交额1.30亿元,主力资金净流出1234.48万元
Xin Lang Cai Jing· 2025-09-19 03:24
Group 1 - The core viewpoint of the news is that Jin'an Guoji's stock has experienced fluctuations, with a year-to-date increase of 70.74% but a recent decline in the last five trading days by 4.39% [1] - As of September 19, the stock price was reported at 13.07 yuan per share, with a total market capitalization of 9.515 billion yuan [1] - The company has seen a net outflow of main funds amounting to 12.3448 million yuan, with significant selling pressure observed [1] Group 2 - Jin'an Guoji's main business involves the research, production, and sales of electronic industry basic materials, specifically copper-clad laminates, which account for 89.50% of its revenue [1] - As of June 30, the company reported a revenue of 2.05 billion yuan for the first half of 2025, reflecting a year-on-year growth of 3.97% [2] - The company has distributed a total of 337 million yuan in dividends since its A-share listing, with 167 million yuan distributed in the last three years [3] Group 3 - The company is categorized under the electronic components sector, specifically in printed circuit boards, and is involved in various concept sectors including small-cap stocks and medical devices [2] - As of June 30, the number of shareholders increased to 44,300, with an average of 16,344 circulating shares per shareholder [2] - The fourth largest circulating shareholder is Hong Kong Central Clearing Limited, holding 5.7163 million shares, which is a decrease of 2.254 million shares from the previous period [3]
明阳电路跌2.01%,成交额1.36亿元,主力资金净流出639.81万元
Xin Lang Cai Jing· 2025-09-19 03:12
Group 1 - The core viewpoint of the news is that Mingyang Circuit experienced a decline in stock price and trading activity, with a notable net outflow of funds [1] - As of September 19, Mingyang Circuit's stock price was 17.57 yuan per share, with a total market capitalization of 6.289 billion yuan [1] - The company has seen a year-to-date stock price increase of 17.06%, but a recent decline of 4.30% over the last five trading days [1] Group 2 - As of June 30, the number of shareholders for Mingyang Circuit increased by 1.35% to 27,900, while the average circulating shares per person decreased by 1.33% to 12,191 shares [2] - For the first half of 2025, Mingyang Circuit reported a revenue of 882 million yuan, representing a year-on-year growth of 13.11%, and a net profit attributable to shareholders of 41.5075 million yuan, up 32.60% year-on-year [2] - Since its A-share listing, Mingyang Circuit has distributed a total of 535 million yuan in dividends, with 209 million yuan distributed over the past three years [2]
世纪鼎利跌2.09%,成交额1.03亿元,主力资金净流出1766.17万元
Xin Lang Cai Jing· 2025-09-19 03:09
Group 1 - The core viewpoint of the news is that Century Dingli's stock has experienced fluctuations, with a recent decline in share price and mixed financial performance indicators [1][2]. - As of September 19, Century Dingli's stock price was 6.56 CNY per share, with a market capitalization of 3.574 billion CNY and a trading volume of 1.03 billion CNY [1]. - The company has seen a year-to-date stock price increase of 22.62%, but has faced a decline of 4.51% over the last five trading days and 3.39% over the last twenty days [1]. Group 2 - Century Dingli reported a revenue of 128 million CNY for the first half of 2025, a year-on-year decrease of 6.87%, while the net profit attributable to shareholders was 8.654 million CNY, showing a significant increase of 160.47% [2]. - The company has a diverse revenue structure, with 60.88% from network optimization and technical services, 26.52% from vocational education services, and smaller contributions from wireless network optimization products and big data products [1]. - Since its A-share listing, Century Dingli has distributed a total of 208 million CNY in dividends, but has not paid any dividends in the last three years [3].
惠发食品跌2.02%,成交额4728.27万元,主力资金净流出104.38万元
Xin Lang Cai Jing· 2025-09-19 02:27
Core Viewpoint - Huhua Food's stock price has experienced a decline of 12.76% year-to-date, with a recent drop of 2.02% on September 19, 2023, indicating potential challenges in the market [1][2]. Company Overview - Huhua Food, established on February 2, 2005, and listed on June 13, 2017, is located in Zhucheng, Shandong Province. The company specializes in the research, production, and sales of frozen food products, including prepared dishes, meatballs, sausages, fried products, and skewers [2]. - The company's revenue composition includes: Supply Chain 34.76%, Meatballs 20.18%, Fried Products 15.20%, Chinese Dishes 9.46%, Sausages 8.43%, Skewers 6.26%, Other 3.27%, Materials and Others 1.77%, and Catering 0.66% [2]. Financial Performance - As of June 30, 2023, Huhua Food reported a total of 25,700 shareholders, a decrease of 0.61% from the previous period, with an average of 9,346 circulating shares per shareholder, an increase of 0.61% [3]. - For the first half of 2023, the company achieved a revenue of 735 million yuan, a year-on-year decrease of 17.75%, and a net profit attributable to shareholders of -29.99 million yuan, a decline of 82.54% year-on-year [3]. Stock Market Activity - Huhua Food's stock has seen a trading volume of 47.28 million yuan with a turnover rate of 1.91% as of September 19, 2023. The stock price was reported at 10.19 yuan per share [1]. - The stock has appeared on the "Dragon and Tiger List" once this year, with the most recent occurrence on March 5, 2023, where it recorded a net purchase of 2.65 million yuan [2].
南新制药跌2.06%,成交额3119.68万元,主力资金净流出417.11万元
Xin Lang Cai Jing· 2025-09-19 02:14
Company Overview - Nanjing Pharmaceutical Co., Ltd. is located in Guangzhou, Guangdong Province, and was established on December 27, 2006. The company was listed on March 26, 2020. Its main business focuses on the research, production, and sales of antiviral drugs for influenza and other infectious diseases, as well as treatments for major diseases such as cardiovascular diseases and diabetes. The revenue composition is 100% from chemical drug formulations [1][2]. Stock Performance - As of September 19, the stock price of Nanjing Pharmaceutical decreased by 2.06%, trading at 12.37 CNY per share, with a total market capitalization of 3.394 billion CNY. The stock has increased by 89.14% year-to-date, but has seen a decline of 4.70% over the last five trading days and 14.81% over the last 20 days [1]. - The company has appeared on the "Dragon and Tiger List" six times this year, with the most recent appearance on August 27, where it recorded a net purchase of 104 million CNY [1]. Financial Performance - For the first half of 2025, Nanjing Pharmaceutical reported a revenue of 61.8463 million CNY, a year-on-year decrease of 71.28%. The net profit attributable to the parent company was -40.0023 million CNY, reflecting a year-on-year decrease of 493.23% [2]. - The company has distributed a total of 40.74 million CNY in dividends since its A-share listing, with no dividends distributed in the past three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders increased by 7.02% to 9,464, while the average circulating shares per person decreased by 6.56% to 28,994 shares [2]. - Among the top ten circulating shareholders, Dazheng Jingheng Mixed A (090019) holds 2.9738 million shares, with no change in the number of shares held compared to the previous period [3].
甬金股份跌2.01%,成交额1.05亿元,主力资金净流出350.85万元
Xin Lang Cai Jing· 2025-09-18 06:54
Core Viewpoint - Yongjin Co., Ltd. has experienced a decline in stock price and trading activity, indicating potential challenges in its market performance and investor sentiment [1][2]. Group 1: Stock Performance - As of September 18, Yongjin's stock price decreased by 2.01%, trading at 17.56 CNY per share with a total market capitalization of 6.42 billion CNY [1]. - Year-to-date, Yongjin's stock price has fallen by 1.31%, with a 3.83% drop over the last five trading days and a 4.77% decline over the past 20 days [2]. - The company has appeared on the trading leaderboard twice this year, with the most recent instance on June 12, where it recorded a net buy of -60.64 million CNY [2]. Group 2: Financial Performance - For the first half of 2025, Yongjin reported a revenue of 20.125 billion CNY, reflecting a year-on-year decrease of 0.85%, while the net profit attributable to shareholders was 303 million CNY, down 29.14% year-on-year [2]. - Since its A-share listing, Yongjin has distributed a total of 1.175 billion CNY in dividends, with 663 million CNY paid out over the last three years [3]. Group 3: Shareholder and Institutional Holdings - As of June 30, 2025, Yongjin had 20,000 shareholders, an increase of 2.42% from the previous period, with an average of 18,248 shares held per shareholder, down 2.37% [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 12.4842 million shares, an increase of 32,800 shares from the previous period [3].
华康洁净跌2.20%,成交额9335.54万元,主力资金净流出370.29万元
Xin Lang Cai Jing· 2025-09-18 06:52
Core Viewpoint - The stock of Huakang Clean has experienced fluctuations, with a year-to-date increase of 60.86% but a recent decline in the last five and twenty trading days [1][2]. Company Overview - Huakang Clean is based in Wuhan, Hubei Province, and was established on November 12, 2008, with its listing date on January 28, 2022. The company specializes in the research, design, implementation, and operation of medical purification systems, along with the sale of related medical equipment and consumables [1]. - The revenue composition of Huakang Clean includes: 85.24% from purification system integration, 8.53% from medical consumables sales, 3.74% from medical equipment sales, 1.88% from operation services, and 0.61% from other sources [1]. Financial Performance - For the first half of 2025, Huakang Clean achieved an operating income of 835 million yuan, representing a year-on-year growth of 50.73%. The net profit attributable to the parent company was 18.68 million yuan, showing a significant increase of 273.48% [2]. - Since its A-share listing, Huakang Clean has distributed a total of 40.02 million yuan in dividends, with 29.46 million yuan distributed over the past three years [3]. Shareholder Information - As of September 10, 2023, Huakang Clean had 10,300 shareholders, a decrease of 8.37% from the previous period. The average number of circulating shares per person increased by 9.14% to 7,056 shares [2]. - Notable institutional holdings include Anxin Medical Health Stock A as the fifth largest shareholder with 652,800 shares, and Nuoan Multi-Strategy Mixed A as the tenth largest shareholder with 429,900 shares, both being new shareholders [3].